AVI BioPharma, Inc. (NASDAQ: AVII) today announced that it received an orphan drug designation from the Committee for Orphan Medical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE